Objective: People with eating disorders (EDs) tend to engage in behaviours that are ordinarily perceived as normal in society, such as restrictive dieting. However, when people are diagnosed with an ED, they may often feel stigmatized, which is likely to act as a barrier to recovery. To date, there is a limited understanding of how stigma of EDs impacts recovery-related outcomes.
Method: A systematic search was performed using PsychINFO and PubMed. Multiple combined searches of terms relating to stigma, EDs, and recovery-related outcomes were conducted. PRISMA guidelines were followed throughout the selection process and resulted in nine studies meeting specific inclusion criteria. The extracted data are examined in a critical narrative synthesis.
Results: Our review suggested that across different samples and measures, stigmatization of EDs is negatively related to a range of factors important for recovery. These include psychological, social and physical health outcomes, ED psychopathology and treatment-seeking behaviours.
Conclusions: Based on the quality assessment, it was concluded that future research would benefit from the use of research designs that can demonstrate causality and generalize findings across community samples. Therefore, in order to improve recovery-related outcomes, treatment plans must consider the type of ED stigma experienced and its relation with specific recovery-related outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/erv.2735 | DOI Listing |
J Psychiatr Ment Health Nurs
December 2024
Psychiatric and Mental Health Nursing Department, Faculty of Nursing, Alexandria University, Alexandria, Egypt.
Introduction: Early maladaptive schemas (EMSs) are among the key vulnerability factors explaining the development and persistence of symptoms in borderline personality disorder (BPD). Furthermore, it was suggested that EMSs might impact recovery-related outcomes, including psychological and recovery capital, among individuals with BPD.
Aims: To investigate the relationship among EMSs, psychological and recovery capital in individuals with BPD disorder.
PLoS One
December 2024
Lighthouse Institute, Chestnut Health Systems, Chicago, Illinois, United States of America.
J Neurotrauma
November 2024
Departments of Pediatric Neurology and Epilepsy, Corewell Health East, Beaumont Children's Hospital, Royal Oak, Michigan, USA.
Control over symptoms postconcussion is central to an active self-directed recovery process. Therefore, assessing a patient's confidence in controlling their symptoms and facilitating their concussion recovery is an important component of treatment. Previously, no measures existed to assess symptom-specific self-efficacy (SE) in pediatric concussion recovery.
View Article and Find Full Text PDFMol Biol Rep
November 2024
Department of Anatomy, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran.
Medicine (Baltimore)
October 2024
Department of Orthopedic, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region, China.
This study aims to explore the clinical efficacy and feasibility of preoperative 1-week chemotherapy for patients with spinal tuberculosis (STB) undergoing complete lesion removal. Clinical data of 76 patients with STB who underwent complete focal debridement in our hospital were collected from June 2020 to September 2023. The patients were divided into 38 cases of preoperative 1-week chemotherapy group (Group A) according to the length of preoperative chemotherapy, and 38 cases of preoperative 2 to 4-week chemotherapy group (Group B).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!